Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer

被引:56
|
作者
Zhou, Yujuan
Liao, Qianjin
Han, Yaqian
Chen, Jie
Liu, Zhigang
Ling, Hang
Zhang, Jing
Yang, Wenjuan
Oyang, Linda
Xia, Longzheng
Wang, Li
Wang, Heran
Xue, Lei
Wang, Hui [1 ,2 ]
Hu, Bingqiang [1 ,2 ]
机构
[1] Cent South Univ, Hunan Canc Hosp, Key Lab Translat Radiat Oncol, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
来源
JOURNAL OF CANCER | 2016年 / 7卷 / 14期
基金
中国国家自然科学基金;
关键词
non-small cell lung cancer; Rac1; epithelial-mesenchymal transition; prognosis; markers; radiotherapy; POTENTIAL THERAPEUTIC TARGET; RADIORESISTANT HEAD; GAMMA-IRRADIATION; INHIBITION; EXPRESSION; INVASION; REARRANGEMENTS; METASTASIS; STATISTICS; CARCINOMA;
D O I
10.7150/jca.16198
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Ras-related C3 botulinum toxin substrate1(Rac1) and epithelial mesenchymal transition (EMT) are key therapeutic targets in cancer. We investigated the clinical significance of Rac1 and markers of EMT expression in non-small cell lung cancer (NSCLC), and their possible correlation with EMT phenotype. Methods: Immunohistochemistry was used to assess the expression of Rac1, Snail1, Twist1, N-cadherin (N-cad), Vimentin (Vim), and E-cadherin (E-cad) in 153 NSCLC paraffin-embedded specimens and 45 normal specimens adjacent to tumors. The correlation of Rac1 and EMT markers with clinicopathological characteristics and the relationship between the protein levels and progression-free survival (PFS) and overall survival (OS) were analyzed. Results: Compared with non-tumor tissues, the NSCLC tissues showed marked elevation in the levels of Rac1, Snail1, Twist1, N-cad, and Vim levels, whereas the E-cad levels were significantly decreased (P < 0.05). The aberrant expression of Rac1 and EMT markers was significantly associated with TNM stage and metastasis (P < 0.05). Increased expression of Rac1 may be associated with poor OS and PFS compared with low expression (P<0.001 and P=0.004). Significant correlations were observed between the EMT markers expressed and OS or PFS(P<0.01). In addition, multivariate analysis indicated that the expression of Rac1, Snail1, Twist1, N-cad, Vim, and E-cad was an independent prognostic factor in NSCLC. Interestingly, Rac1 expression was positively correlated with Snail1, Twist1, N-cad, and Vim levels (r=0.563, r=0.440, r=0.247 r=0.536, P<0.01, respectively) and negatively correlated with E-cad levels (r=-0.464, P<0.001) in NSCLC tissues. Rac1, Twist, Snail1, Vim and N-cad were highly expressed in lung cancer patients resistant to radiotherapy, while E-cad was poorly expressed. Conclusion: Rac1 may promote NSCLC progression and metastasis via EMT, which may be considered as a potential therapeutic target.
引用
收藏
页码:2100 / 2109
页数:10
相关论文
共 50 条
  • [1] Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
    Hong, Ling-Zhi
    Wei, Xiao-Wei
    Chen, Jin-Fei
    Shi, Yi
    [J]. ONCOLOGY LETTERS, 2013, 6 (06) : 1595 - 1603
  • [2] MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer
    Zhiqiang Wang
    Zhi Li
    Chen Wu
    Yonggong Wang
    Yang Xia
    Liang Chen
    Quan Zhu
    Yijiang Chen
    [J]. Medical Oncology, 2014, 31
  • [3] Fascin-1 overexpression predicts a poor prognosis in non-small cell lung cancer
    Li, Dan
    Li, Weimin
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [4] MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer
    Wang, Zhiqiang
    Li, Zhi
    Wu, Chen
    Wang, Yonggong
    Xia, Yang
    Chen, Liang
    Zhu, Quan
    Chen, Yijiang
    [J]. MEDICAL ONCOLOGY, 2014, 31 (01)
  • [5] PPM1D overexpression predicts poor prognosis in non-small cell lung cancer
    Yang, Hua
    Gao, Xiao-Yu
    Li, Ping
    Jiang, Ting-Shu
    [J]. TUMOR BIOLOGY, 2015, 36 (03) : 2179 - 2184
  • [6] SCUBE3 overexpression predicts poor prognosis in non-small cell lung cancer
    Zhao, Chao
    Qin, Qin
    Wang, Qianqian
    Zhang, Jianrong
    Xu, Yulian
    Li, Wenjie
    Gu, Mingli
    Chen, Sunxiao
    Deng, Anmei
    [J]. BIOSCIENCE TRENDS, 2013, 7 (06) : 264 - 269
  • [7] Mortalin overexpression predicts poor prognosis in early stage of non-small cell lung cancer
    Sun, Jie
    Che, Shuan-Long
    Piao, Jun-Jie
    Xu, Ming
    Chen, Li-Yan
    Lin, Zhen-Hua
    [J]. TUMOR BIOLOGY, 2017, 39 (03)
  • [8] Overexpression of PSAT1 is Correlated with Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer
    Li, Hongmu
    Wu, Chun
    Chang, Wuguang
    Zhong, Leqi
    Gao, Wuyou
    Zeng, Mingyue
    Wen, Zhesheng
    Mai, Shijuan
    Chen, Youfang
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (10):
  • [9] Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancer
    Takeshita, Masafumi
    Koga, Takaomi
    Takayama, Koichi
    Ijichi, Kayo
    Yano, Tokujiro
    Maehara, Yoshihiko
    Nakanishi, Yoichi
    Sueishi, Katsuo
    [J]. LUNG CANCER, 2013, 80 (01) : 85 - 90
  • [10] Epithelial-mesenchymal transition in non-small cell lung cancer
    Soltermann, A.
    [J]. PATHOLOGE, 2012, 33 : 311 - 317